BridgeBio is demonstrably improved the progress of a new solution for ATTR-CM, leveraging Attruby. Preliminary clinical information suggests promising improvements for patients diagnosed from this severe condition. The https://bridgebio172899.blogprodesign.com/63567871/company-advances-cardiac-amyloidosis-management-using-the-therapy